MA51971B2 - STEROIDS AND THEIR PROTEIN CONJUGATES - Google Patents
STEROIDS AND THEIR PROTEIN CONJUGATESInfo
- Publication number
- MA51971B2 MA51971B2 MA51971A MA51971A MA51971B2 MA 51971 B2 MA51971 B2 MA 51971B2 MA 51971 A MA51971 A MA 51971A MA 51971 A MA51971 A MA 51971A MA 51971 B2 MA51971 B2 MA 51971B2
- Authority
- MA
- Morocco
- Prior art keywords
- steroids
- protein conjugates
- protein
- conjugates
- glucocorticoids
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 150000003431 steroids Chemical class 0.000 title abstract 2
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 229940037128 systemic glucocorticoids Drugs 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des conjugués de stéroïdes protéiques qui sont utiles, par exemple, pour l'administration spécifique à une cible de glucocorticoïdes (gc) à des cellules.The invention relates to protein steroid conjugates that are useful, for example, for target-specific delivery of glucocorticoids (gc) to cells.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662419365P | 2016-11-08 | 2016-11-08 | |
| PCT/US2017/060434 WO2018089373A2 (en) | 2016-11-08 | 2017-11-07 | Steroids and protein-conjugates thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA51971A1 MA51971A1 (en) | 2022-06-30 |
| MA51971B2 true MA51971B2 (en) | 2024-05-31 |
Family
ID=72291376
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA51970A MA51970B1 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
| MA51969A MA51969B2 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
| MA45752A MA45752B2 (en) | 2016-11-08 | 2017-11-07 | Steroids and their protein conjugates |
| MA51971A MA51971B2 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA51970A MA51970B1 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
| MA51969A MA51969B2 (en) | 2016-11-08 | 2017-11-07 | STEROIDS AND THEIR PROTEIN CONJUGATES |
| MA45752A MA45752B2 (en) | 2016-11-08 | 2017-11-07 | Steroids and their protein conjugates |
Country Status (2)
| Country | Link |
|---|---|
| CL (1) | CL2023000971A1 (en) |
| MA (4) | MA51970B1 (en) |
-
2017
- 2017-11-07 MA MA51970A patent/MA51970B1/en unknown
- 2017-11-07 MA MA51969A patent/MA51969B2/en unknown
- 2017-11-07 MA MA45752A patent/MA45752B2/en unknown
- 2017-11-07 MA MA51971A patent/MA51971B2/en unknown
-
2023
- 2023-04-04 CL CL2023000971A patent/CL2023000971A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA51969B2 (en) | 2024-05-31 |
| MA51970B1 (en) | 2023-11-30 |
| MA45752A1 (en) | 2020-06-30 |
| MA51969A1 (en) | 2022-08-31 |
| MA45752B2 (en) | 2022-12-30 |
| MA51970A1 (en) | 2022-08-31 |
| MA51971A1 (en) | 2022-06-30 |
| CL2023000971A1 (en) | 2023-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA50259A1 (en) | Steroids and their antibody conjugates | |
| PH12019500365A1 (en) | Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods | |
| MA49726B1 (en) | ANTI-CGRP ANTIBODY FORMULATION | |
| MA45029A (en) | ANTI-PD-1 AND ANTI-LAG3 ANTIBODIES FOR CANCER TREATMENT | |
| MX2023011657A (en) | Compositions comprising curons and uses thereof. | |
| JOP20200228A1 (en) | Compositions and methods for decreasing tau expression | |
| JOP20200157B1 (en) | Heavy chain antibodies that bind to CD22 | |
| BR112021016056A2 (en) | Claudin 6 antibodies and their uses | |
| MA40513A (en) | DRUG-ANTIBODY ANTI-CDH6 CONJUGATES | |
| MA40132B1 (en) | Macrocyclic Inhibitors of Protein / protein Interactions pd-1 / pd-11 and cd80 (b7-1) / pd-li | |
| MA41013B1 (en) | Compositions comprising bacterial strains | |
| BR112018016450A2 (en) | vcn enhancer compositions and methods of using them | |
| MA46619B1 (en) | Anti-il-33 antibodies and their uses | |
| PH12019502025A1 (en) | Anti-tigit antigen-binding proteins and methods of use thereof | |
| MA43773B1 (en) | Engineered immunoglobulins with altered FcRn binding | |
| MX2021006945A (en) | Anellosomes for delivering protein replacement therapeutic modalities. | |
| BR112018009004A8 (en) | anti-cd3-folate conjugates and their uses | |
| MX2021003797A (en) | Immunoablative therapies. | |
| MX2020003219A (en) | Antibodies having specificity for btn2 and uses thereof. | |
| MX2021006941A (en) | Anellosomes for delivering intracellular therapeutic modalities. | |
| MY191894A (en) | Antibodies that bind zika virus envelope protein and uses thereof | |
| MX390865B (en) | Compositions and methods for the treatment of complications and disorders relating to von willebrand factor | |
| MX2020013389A (en) | Terlipressin compositions and uses thereof. | |
| MA51969B2 (en) | STEROIDS AND THEIR PROTEIN CONJUGATES | |
| EA201900275A1 (en) | STEROIDS AND THEIR PROTEIN CONJUGATES |